Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Non-Current Assets (2023 - 2026)

Camp4 Therapeutics' Other Non-Current Assets history spans 3 years, with the latest figure at $894000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 44.95% to $894000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $894000.0, a 44.95% decrease, with the full-year FY2025 number at $894000.0, down 44.95% from a year prior.
  • Other Non-Current Assets hit $894000.0 in Q4 2025 for Camp4 Therapeutics, down from $1.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CAMP hit a ceiling of $1.6 million in Q3 2023 and a floor of $894000.0 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $1.5 million across 3 years, with a median of $1.6 million in 2023.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2024 and later plummeted 44.95% in 2025.
  • Tracing CAMP's Other Non-Current Assets over 3 years: stood at $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then tumbled by 44.95% to $894000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for CAMP at $894000.0 in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.